The Medicines Company (NASDAQ:MDCO)

CAPS Rating: 4 out of 5

A pharmaceutical company provides innovative, cost effective acute care hospital products to the worldwide hospital marketplace.


Player Avatar zzlangerhans (99.80) Submitted: 2/20/2009 1:07:40 PM : Outperform Start Price: $12.61 MDCO Score: +11.75

It's not clear to me why Medicines has fallen so far despite a relatively stable financial picture. Angiomax revenues have been increasing and generics will not be available before 2010 at the earliest. That gives Medicines time to grow Cleviprex revenues and develop their pipeline. I'm not really a bull here but this company has the tools to survive and will likely be one to rebound in the short term when the market stabilizes, given no major negative catalysts.

Featured Broker Partners